ProCE Banner Series

Integrating New Data From AIDS 2024: Pharmacist Perspectives

Join HIV pharmacist experts as they discuss integrating the latest data from AIDS 2024 into practice.

  ACPE
Who Should Attend

This program is intended for pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection.

All Events

Integrating New Data From AIDS 2024: Pharmacist Perspectives

Upcoming Events

August

08

2024

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

August

22

2024

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Jennifer Cocohoba, PharmD, AAHIVP

Professor of Clinical Pharmacy
Department of Clinical Pharmacy
University of California San Francisco School of Pharmacy
San Francisco, California

ProCE Banner Faculty
David Koren, PharmD, MPH, AAHIVP, FIDSA

Adjunct Clinical Professor
Temple University School of Pharmacy
Clinical Pharmacist Specialist
Temple University Health System
Philadelphia, Pennsylvania

Topics

HIV

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary antiretroviral regimens. 

Target Audience
This program is intended for pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies
  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC, and the American Academy of HIV Medicine. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-24-115-L02-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with the American Academy of HIV Medicine

Supported by an educational grant from ViiV Healthcare.